Role of TRAIL and IFN-γ in CD4+ T cell-dependent tumor rejection in the anterior chamber of the eye

Journal of Immunology

Volumn 171, Issue 6, 2003, Pages 2789-2796

  Wang, Shixuan ^a   Boonman, Zita F H M ^b   Li, Hao Chuan ^a   He, YuGuang ^a   Jager, Martine J ^b   Toes, Rene E M ^b   Niederkorn, Jerry Y ^a,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; FAS LIGAND; GAMMA INTERFERON; PERFORIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADENOVIRUS 5; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR EYE CHAMBER; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CANCER TRANSPLANTATION; CONTROLLED STUDY; CORNEA ENDOTHELIUM; ENDOTHELIUM CELL; EYE TUMOR; KNOCKOUT MOUSE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL; TUMOR REJECTION;

EID: 0042333471     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.6.2789     Document Type: Article

References (39)

1. Niederkorn, J. Y. 2002. Immune privilege in the anterior chamber of the eye. Crit. Rev. Immunol. 22:13.
2. Williams, K. A., J. K. Ash, and D. J. Coster. 1985. Histocompatibility antigen and passenger cell content of normal and diseased human cornea. Transplantation 39:265.
3. Whitsett, C. F., and R. D. Stulting. 1984. The distribution of HLA antigens on human corneal tissue. Invest. Ophthalmol. Visual Sci. 25:519.
4. Fujikawa, L. S., R. B. Colvin, A. K. Bhan, T. C. Fuller, and S. Foster. 1982. Expression of HLA-A/B/C and -DR locus antigens on epithelial, stromal, and endothelial cells from the human cornea. Cornea 1:213.
5. Newsome, D. A., M. Takasugi, K. R. Kenyon, W. F. Stark, and G. Opelz. 1974. Human corneal cells in vitro: morphology and histocompatibility (HL-A) antigens of pure cell populations. Invest. Ophthalmol. 13:23.
6. Osterlind, A. 1987. Trends in incidence of ocular malignant melanoma in Denmark 1943-1982. Int. J. Cancer 40:161.
7. Niederkorn, J. Y. 1995. Immunopathogenesis of intraocular tumors. Prog. Retinal and Eye Res. 14:505.
8. Niederkorn, J. Y. 1991. The immunopathology of intraocular tumour rejection. Eye 5:186.
9. Niederkorn, J. Y. 1997. Immunoregulation of intraocular tumours. Eye 11:249.
10. Lee, H. O., J. M. Herndon, R. Barreiro, T. S. Griffith, and T. A. Ferguson. 2002. TRAIL: a mechanism of tumor surveillance in an immune privileged site. J. Immunol. 169:4739.
11. + T cells without induction of phthisis. J. Immunol. 167:5832.
12. Senik, A., I. Gresser, C. Maury, M. Gidlund, A. Orn, and H. Wigzell. 1979. Enhancement by interferon of natural killer cell activity in mice. Cell. Immunol. 44:186.
13. + T cell killing of antigen-presenting macrophages. J. Immunol. 164:2897.
14. + T cell-mediated cytotoxicity. J. Immunol. 162:2639.
15. Thomas, W. D., and P. Hersey. 1998. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells. J. Immunol. 161:2195.
16. Toes, R. E., R. Offringa, R. J. Blom, R. M. Brandt, A. J. van der Eb, C. J. Melief, and W. M. Kast. 1995. An adenovirus type 5 early region 1B-encoded CTL epitope-mediating tumor eradication by CTL clones is down-modulated by an activated ras oncogene. J. Immunol. 154:3396.
17. Kast, W. M., R. Offringa, P. J. Peters, A. C. Voordouw, R. H. Meloen, A. J. van der Eb, and C. J. Melief. 1989. Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes. Cell 59:603.
18. Niederkorn, J., J. W. Streilein, and J. A. Shadduck. 1981. Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice. Invest. Ophthalmol. Visual Sci. 20:355.
19. Bantel, H., A. Lugering, C. Poremba, N. Lugering, J. Held, W. Domschke, and K. Schulze-Osthoff. 2001. Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection. Hepatology 34:758.
20. Hahn, Y. S., C. Soguero, and M. Cruise. 2001. Towards a reliable parameter of liver damage in hepatitis C: TUNEL versus caspase activation. Hepatology 34:840.
21. He, Y. G., J. Mellon, and J. Y. Niederkorn. 1996. The effect of oral immunization on corneal allograft survival. Transplantation 61:920.
22. Ma, D., X. Y. Li, J. Mellon, and J. Y. Niederkorn. 1998. Immunologic phenotype of hosts orally immunized with corneal alloantigens. Invest. Ophthalmol. Visual Sci. 39:744.
23. Wilson, S. E., J. Weng, S. Blair, Y. G. He, and S. Lloyd. 1995. Expression of E6/E7 or SV40 large T antigen-coding oncogenes in human corneal endothelial cells indicates regulated high-proliferative capacity. Invest. Ophthalmol. Visual Sci. 36:32.
24. Streilein, J. W., and D. Bradley. 1991. Analysis of immunosuppressive properties of iris and ciliary body cells and their secretory products. Invest. Ophthalmol. Visual Sci. 32:2700.
25. Niederkorn, J. Y., E. Y. Chiang, T. Ungchusri, and I. Stroynowski. 1999. Expression of a nonclassical MHC class Ib molecule in the eye. Transplantation 68:1790.
26. Rajalingam, K., H. Al-Younes, A. Muller, T. F. Meyer, A. J. Szczepek, and T. Rudel. 2001. Epithelial cells infected with Chlamydophila pneumoniae (Chlamydia pneumoniae) are resistant to apoptosis. Infect. Immun. 69:7880.
27. Smyth, M. J., E. Cretney, K. Takeda, R. H. Wiltrout, L. M. Sedger, N. Kayagaki, H. Yagita, and K. Okumura. 2001. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon γ-dependent natural killer cell protection from tumor metastasis. J. Exp. Med. 193:661.
28. + immunoregulatory T cells is antigen nonspecific. J. Immunol. 164:183.
29. + cytotoxic T cells. Proc. Natl. Acad. Sci. USA 91:4185.
30. + T cell-mediated cytotoxicity. J. Immunol. 152:1127.
31. Nickerson, P., W. Steurer, J. Steiger, X. Zheng, A. W. Steele, and T. B. Strom. 1994. Cytokines and the Th1/Th2 paradigm in transplantation. Curr. Opin. Immunol. 6:757.
32. Dallman, M. J. 1995. Cytokines and transplantation: Th1/Th2 regulation of the immune response to solid organ transplants in the adult. Curr. Opin. Immunol. 7:632.
33. Routes, J. M., S. Ryan, A. Clase, T. Miura, A. Kuhl, T. A. Potter, and J. L. Cook. 2000. Adenovirus E1A oncogene expression in tumor cells enhances killing by TNF-related apoptosis-inducing ligand (TRAIL). J. Immunol. 165:4522.
34. Meng, R. D., and W. S. El-Deiry. 2001. p53-independent up-regulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferon-γ. Exp. Cell Res. 262:154.
35. Niederkorn, J. Y., and T. L. Knisely. 1988. Immunological analysis of a destructive pattern of intraocular tumor resolution. Curr. Eye Res. 7:515.
36. Knisely, T. L., M. W. Luckenbach, B. J. Fischer, and J. Y. Niederkorn. 1987. Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors. J. Immunol. 138:4515.
37. Ma, D., H. Alizadeh, S. A. Comerford, M. J. Gething, J. F. Sambrook, R. Anand, and J. Y. Niederkorn. 1994. Rejection of intraocular tumors from transgenic mice by tumor-infiltrating lymphocytes. Curr. Eye Res. 13:361.
38. Knisely, T. L., and J. Y. Niederkorn. 1990. Emergence of a dominant cytotoxic T lymphocyte antitumor effector from tumor-infiltrating cells in the anterior chamber of the eye. Cancer Immunol. Immunother. 30:323.
39. Takeda, K., Y. Hayakawa, M. J. Smyth, N. Kayagaki, N. Yamaguchi, S. Kakuta, Y. Iwakura, H. Yagita, and K. Okumura. 2001. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat. Med. 7:94.